Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model

Atherosclerosis

Volumn 202, Issue 1, 2009, Pages 144-151

  Farhan, Serdar ^a   Hemetsberger, Rayyan ^b   Matiasek, Johannes ^b   Strehblow, Christoph ^b   Pavo, Noemi ^b   Khorsand, Aliasghar ^b   Petneházy, Örs ^c   Petrási, Zsolt ^c   Kaider, Alexandra ^b   Glogar, Dietmar ^b   Huber, Kurt ^a   Gyöngyösi, Mariann ^b  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

Acetylcholine; Coronary pressure; Nitroglycerine; Stents; Vasodilation

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; PACLITAXEL;

ANIMAL EXPERIMENT; ARTERIAL STIFFNESS; ARTERY INJURY; ARTICLE; BARE METAL STENT; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL WALL; CONTROLLED STUDY; CORONARY ARTERY PRESSURE; DRUG ELUTING STENT; ECHOCARDIOGRAPHY; FEMALE; FIBRIN DEPOSITION; HISTOPATHOLOGY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FEMALE; INFLAMMATION; MALE; METALS; NITROGLYCERIN; PACLITAXEL; SWINE; VASODILATION;

EID: 57649155322     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.04.039     Document Type: Article

References (28)

1. Glasser S.P., Arnett D.K., McVeigh G.E., et al. Vascular compliance and cardiovascular disease. A risk factor or a marker?. Am J Hyperten 10 (1997) 1175-1189
2. McVeigh G.E., Hamilton P.K., and Morgan D.R. Evaluation of mechanical arterial properties: clinical, experimental and therapeutic aspects. Clin Sci 102 (2002) 51-67
3. Zieman S.J., Melenovsky V., and Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25 (2005) 932-943
4. Jeremias A., Spies C., Herity N.A., et al. Coronary artery compliance and adaptive vessel remodeling in patients with stable and unstable coronary artery disease. Heart 84 (2000) 314-319
5. McLeod A.L., Newby D.E., Northridge D.B., Fox K.A.A., and Uren N.G. Influence of differential vascular remodeling on the coronary vasomotor response. Cardiovasc Res 59 (2003) 520-526
6. Hofma S.H., van der Giessen J., van Dalen B.M., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 166-170
7. De Bruyne B., Bartunek J., Sys S.U., and Heyndrickx G.R. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 92 (1995) 93-96
8. Pijls N.H., De Bruyne B., Peels K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996) 1703-1708
9. Kern M.J., Lerman A., Bech J.W., et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American heart association committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology. Circulation 114 (2006) 1321-1341
10. Virmani R., Kolodgie F.D., Farb A., and Lafont A. Drug eluting stents: are human and animal studies comparable?. Heart 89 (2003) 133-138
11. Morice M.C., Serruys P.W., Sousa J.E., et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions a randomized comparison of a sirolimius-eluting stent with a standard stent coronary revascularization. N Engl J Med 346 (2002) 11773-11780
12. Schwartz R.S., Chorones N.A., and Virmani R. Preclinical restenosis model and drug-eluting stents. Still important, still much to learn. J Am Coll Cardiol 44 (2004) 1373-1385
13. Sousa J.E., Costa M.A., Abizaid A.C., et al. Sustained suppression of neointima proliferation by sirolimus eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104 (2001) 2007-2011
14. Togni M., Räber L., Cocchia R., et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 120 (2007) 212-220
15. Schwartz R.S. Edelman ER for the consensus committee: drug-eluting stents in preclinical studies recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
16. Schwartz R.S., Huber K.C., Murphy J.G., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19 (1992) 267-274
17. Gyöngyösi M., Strehblow C., Sperker W., et al. Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 h. Thromb Haemost 96 (2006) 202-209
18. Gyöngyösi M., Yang P., Hassan A., et al. Arterial remodeling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study. Heart 82 (1999) 68-74
19. Nakatani S., Yamagishi M., Tamai J., et al. Assessment of coronary artery distensibility by intravascular ultrasound. Circulation 91 (1995) 2904-2910
20. Yamagishi M., Umeno T., Hongo Y., et al. Intravascular ultrasonic evidence for importance of plaque distribution (eccentric vs circumferential) in determining distensibility of the left anterior descending artery. Am J Cardiol 79 (1997) 1596-1600
21. Woodman R.J., Watts G.F., Kingwell B.A., and Dart A.M. Interpretation of the digital volume pulse: its relationship with large and small artery compliance. Clin Sci 104 (2003) 283-285
22. Garg P., and Mauri L. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Curr Opin Cardiol 22 (2007) 565-571
23. Virmani R., Liistro F., Stankovic G., et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 106 (2002) 2649-2651
24. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
25. Huo Y., and Kassab G.S. Pulsatile blood flow in the entire coronary arterial tree: theory and experiment. Am J Physiol Heart Circ Physiol 291 (2006) 1074-1087
26. Herrmann J., Saguner A.M., Versari D., et al. Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res 101 (2007) 865-874
27. Houghton J.L., Davison C.A., Kuhner P.A., Torossov M.T., Strogatz D.S., and Carr A.A. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension. J Am Coll Cardiol 31 (1998) 374-382
28. Schwartz R.S., and Henry T.D. Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med 3 (2002) S4-S9